483 Document: Salil U. Nadkarni, DO, Sep 24, 2021

FDANews 483 Salil U. Nadkarni, DO Sep 24 2021 top
Julian C. Hanson FDA Investigator

On Sep 24, 2021, the FDA inspected Salil U. Nadkarni, DO's Los Angeles site. Explore the inspectional observations.